Mayo, T., Armstrong, A., Kircik, L., Silverberg, J., Blauvelt, A., Esdaile, B., Schneider, S., Mark, T., Gooderham, M. and Alexis, A. 2023. Efficacy and safety of up to two years of tralokinumab treatment in adults of different racial subgroups with moderate-to-severe atopic dermatitis. SKIN The Journal of Cutaneous Medicine. 7, 2 (Mar. 2023), s144. DOI:https://doi.org/10.25251/skin.7.supp.144.